• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TM6SF2 E167K变异体过表达促进肝癌细胞系HEPA 1-6中炎性细胞因子的表达。

TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6.

作者信息

Du Shuixian, Liao Songling, Liu Shousheng, Xin Yongning

机构信息

Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, China.

Department of Gastroenterology, Dalian Medical University, Dalian, China.

出版信息

J Clin Transl Hepatol. 2019 Mar 28;7(1):27-31. doi: 10.14218/JCTH.2018.00055. Epub 2019 Feb 8.

DOI:10.14218/JCTH.2018.00055
PMID:30944816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6441636/
Abstract

Accumulated evidence has shown that chronic liver inflammation is one of the main risks of hepatocellular carcinoma (HCC), and E167K variant of the transmembrane 6 superfamily member 2 (TM6SF2) plays an important role in the progression of chronic liver diseases and HCC. The aim of this study was to explore effects of the TM6SF2 E167K variant on expression of the inflammatory cytokines TNF-α, IL-2, IL-6 and IL-8 in the HCC cell line HEPA 1-6. HEPA 1-6 cells were infected with lentivirus containing either the TM6SF2 E167K variant or TM6SF2 wild-type, or control plasmids. Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting were conducted to analyze the expression of the inflammatory cytokines TNF-α, IL-2, IL-6 and IL-8. A t-test was used for statistical analysis. Compared with the control group and TM6SF2 overexpression group, the relative expression of IL-2 and IL-6 mRNAs were significantly elevated in the TM6SF2 E167K overexpression group ( < 0.05). The relative mRNA expression of IL-8 in the TM6SF2 and TM6SF2 E167K overexpression groups were increased compared to the control group ( < 0.05). No obvious differences were observed for the expression of TNF-α in each group. The expression of TNF-α, IL-2, IL-6 and IL-8 that was tested by western blotting showed the same trends as the qRT-PCR results. In conclusion, the E167K variant of the TM6SF2 gene could promote the expression of inflammatory cytokines IL-2 and IL-6 in HEPA 1-6 cells, suggesting that the TM6SF2 E167K variant may accelerate the progression of HCC.

摘要

越来越多的证据表明,慢性肝脏炎症是肝细胞癌(HCC)的主要风险之一,跨膜6超家族成员2(TM6SF2)的E167K变体在慢性肝病和HCC的进展中起重要作用。本研究的目的是探讨TM6SF2 E167K变体对肝癌细胞系HEPA 1-6中炎性细胞因子TNF-α、IL-2、IL-6和IL-8表达的影响。用含有TM6SF2 E167K变体或TM6SF2野生型的慢病毒或对照质粒感染HEPA 1-6细胞。采用定量实时聚合酶链反应(qRT-PCR)和蛋白质印迹法分析炎性细胞因子TNF-α、IL-2、IL-6和IL-8的表达。采用t检验进行统计学分析。与对照组和TM6SF2过表达组相比,TM6SF2 E167K过表达组中IL-2和IL-6 mRNA的相对表达显著升高(<0.05)。与对照组相比(<0.05),TM6SF2和TM6SF2 E167K过表达组中IL-8的相对mRNA表达增加。各组TNF-α的表达未观察到明显差异。蛋白质印迹法检测的TNF-α、IL-2、IL-6和IL-8的表达与qRT-PCR结果显示出相同趋势。总之,TM6SF2基因的E167K变体可促进HEPA 1-6细胞中炎性细胞因子IL-2和IL-6的表达,提示TM6SF2 E167K变体可能加速HCC的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa7/6441636/959be3b2201b/JCTH-7-027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa7/6441636/3171a6461b3d/JCTH-7-027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa7/6441636/959be3b2201b/JCTH-7-027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa7/6441636/3171a6461b3d/JCTH-7-027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa7/6441636/959be3b2201b/JCTH-7-027-g002.jpg

相似文献

1
TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6.TM6SF2 E167K变异体过表达促进肝癌细胞系HEPA 1-6中炎性细胞因子的表达。
J Clin Transl Hepatol. 2019 Mar 28;7(1):27-31. doi: 10.14218/JCTH.2018.00055. Epub 2019 Feb 8.
2
E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.TM6SF2基因的E167K多态性影响肝癌细胞HEPA 1-6的细胞周期。
Lipids Health Dis. 2017 Apr 13;16(1):76. doi: 10.1186/s12944-017-0468-8.
3
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.TM6SF2 E167K变异体可预测人类免疫缺陷病毒/丙型肝炎病毒合并感染患者的严重肝纤维化,且仅对非3型丙型肝炎病毒基因型患者预测严重脂肪变性。
World J Gastroenterol. 2016 Oct 14;22(38):8509-8518. doi: 10.3748/wjg.v22.i38.8509.
4
TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.TM6SF2 E167K 变异体,一种新的遗传易感性变异体,与非酒精性脂肪性肝病有关。
J Clin Transl Hepatol. 2015 Dec 28;3(4):265-70. doi: 10.14218/JCTH.2015.00023. Epub 2015 Dec 15.
5
The Genetics of Clinical Liver Diseases: Insight into the E167K Variant.临床肝脏疾病的遗传学:对E167K变体的见解
J Clin Transl Hepatol. 2018 Sep 28;6(3):326-331. doi: 10.14218/JCTH.2018.00022. Epub 2018 Sep 7.
6
TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD.TM6SF2 E167K 变异体降低 PNPLA3 介导的多不饱和脂肪酸转移,从而促进 MASLD 中的肝脂肪变性和损伤。
Clin Mol Hepatol. 2024 Oct;30(4):863-882. doi: 10.3350/cmh.2024.0268. Epub 2024 Jul 26.
7
Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.TM6SF2 E167K 和 PNPLA3 I148M 变异体在东北地区非酒精性脂肪性肝病中的相互作用。
Ann Hepatol. 2019 May-Jun;18(3):456-460. doi: 10.1016/j.aohep.2018.10.005. Epub 2019 Apr 15.
8
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.循环三酰甘油特征与 TM6SF2 中的 E167K 变异相关的非酒精性脂肪性肝病患者的胰岛素敏感性。
J Hepatol. 2015 Mar;62(3):657-63. doi: 10.1016/j.jhep.2014.10.010. Epub 2014 Oct 19.
9
TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.TM6SF2 E167K变异与慢性丙型肝炎的严重脂肪变性相关,与PNPLA3基因多态性无关。
Liver Int. 2015 Aug;35(8):1959-63. doi: 10.1111/liv.12781. Epub 2015 Jan 27.
10
Type 2 diabetes sex-specific effects associated with E167K coding variant in .与……中E167K编码变体相关的2型糖尿病性别特异性效应
iScience. 2021 Oct 2;24(11):103196. doi: 10.1016/j.isci.2021.103196. eCollection 2021 Nov 19.

引用本文的文献

1
Impact of differential detection of TM6SF2 rs58542926 mutation in circulating tumor DNA versus peripheral blood cells on hepatocellular carcinoma patients.循环肿瘤DNA与外周血细胞中TM6SF2 rs58542926突变的差异检测对肝细胞癌患者的影响
Discov Oncol. 2025 Jun 12;16(1):1071. doi: 10.1007/s12672-025-02812-9.
2
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.代谢功能障碍相关脂肪性肝病相关肝肿瘤的病理学与发病机制
Biomedicines. 2023 Oct 12;11(10):2761. doi: 10.3390/biomedicines11102761.
3
The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma.

本文引用的文献

1
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.载脂蛋白基因变异与 TM6SF2 基因变异易导致酒精性肝硬化患者发生肝细胞癌。
Am J Gastroenterol. 2018 Oct;113(10):1475-1483. doi: 10.1038/s41395-018-0041-8. Epub 2018 Mar 13.
2
Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis.白细胞介素-8基因多态性及表达与埃及肝硬化患者肝细胞癌的关联
Egypt J Immunol. 2017 Jan;24(1):143-152.
3
Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression.
非酒精性脂肪性肝病相关肝细胞癌的新兴因素及治疗选择
Cancers (Basel). 2021 Jul 26;13(15):3740. doi: 10.3390/cancers13153740.
4
Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.TM6SF2 rs58542926 T/C 基因多态性与肝细胞癌的相关性:荟萃分析。
BMC Cancer. 2019 Nov 21;19(1):1128. doi: 10.1186/s12885-019-6173-4.
Prospero 相关同源盒蛋白 1 通过选择性激活白细胞介素 8 的表达促进肝细胞癌的血管生成。
Hepatology. 2017 Dec;66(6):1894-1909. doi: 10.1002/hep.29337.
4
E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.TM6SF2基因的E167K多态性影响肝癌细胞HEPA 1-6的细胞周期。
Lipids Health Dis. 2017 Apr 13;16(1):76. doi: 10.1186/s12944-017-0468-8.
5
Genetic alterations in hepatocellular carcinoma: An update.肝细胞癌中的基因改变:最新进展
World J Gastroenterol. 2016 Nov 7;22(41):9069-9095. doi: 10.3748/wjg.v22.i41.9069.
6
Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.炎症及其相关微小RNA在肝细胞癌中的作用
Oncotarget. 2017 Mar 28;8(13):22145-22165. doi: 10.18632/oncotarget.13530.
7
Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.携带TRAIL和IL-12基因的溶瘤腺病毒联合治疗在体外和原位移植小鼠模型中均显著抑制人肝细胞癌。
J Exp Clin Cancer Res. 2016 May 6;35:74. doi: 10.1186/s13046-016-0353-8.
8
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.在中国,去γ-羧基凝血酶原与甲胎蛋白对乙型肝炎病毒相关肝细胞癌的诊断评估:一项大规模、多中心研究
PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016.
9
Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.炎症促进乙肝相关肝细胞癌中干性相关特性的表达。
PLoS One. 2016 Feb 26;11(2):e0149897. doi: 10.1371/journal.pone.0149897. eCollection 2016.
10
Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.白细胞介素-6刺激的前颗粒蛋白表达通过激活mTOR信号传导促进肝癌细胞的恶性增殖。
Sci Rep. 2016 Feb 16;6:21260. doi: 10.1038/srep21260.